Learn More
Description
Panel of undiluted serum and plasma samples with anti-Herpes Simplex Virus reactivity ranging from negative to strongly positive; samples were selected to demonstrate IgG and/or IgM reactivity
- Negative plasma and sera are included as nonreactive controls
- Extensive array of panels helps labs maintain the highest standards for assay validation, regulatory compliance and method development
- Each panel includes comprehensive, comparative data from a variety of methods and commercially available test kits, allowing reagent assay/platform performance, sensitivity and specificity to be independently challenged
- Assembled from highly characterized, disease state patient samples, and developed specifically for infectious disease testing
- Enables labs to evaluate, monitor and troubleshoot test and staff performance
- Minimizes down time and accelerates validation and verification of new test methods, reagent systems and platforms
- Rigorously tested and characterized using highest-quality test methods
- Comprehensive test results provided with each panel; quantified against international standards when available
- Long-term stability and availability
- SeraCare facilities are ISO 9001 and 13485 certified and comply with cGMP standards
Specifications
Specifications
| Certifications/Compliance | ISO 9000 13485 |
| Type | ToRCH Anti-HSV Type 1 and 2 Mixed Titer Performance Panel |
| Includes | Undiluted Serum and Plasma samples with anti-Herpes Simplex Virus reactivity ranging from negative to strongly positive |
| Intended Use | Evaluating of Anti-Herpes simplex tests |
| Matrix | Serum and Plasma |
| Quantity | 25 x 0.5 mL |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.